The Joint Translational Research Center for Child Development and Alzheimer's Disease (Chongqing) is the world's first medical research center on the joint transformation of childhood development and Alzheimer's disease. It was sponsored by the Children's Hospital of Chongqing Medical University in January 2011 and British Columbia, Canada. University signed a joint creation.
After the establishment of the center, basic research and translational medicine research will be conducted on children with Down Syndrome, Alzheimer's disease, epilepsy, cerebral palsy, autism, learning and memory disorders, mental retardation and other diseases. It will also work hard to build a China-Canada international cooperation and exchange base to promote China’s comprehensive cooperation with overseas universities, scientific research institutions, and high-tech enterprises in the fields of cognitive development and learning-and-memory-related diseases.
The research center hired the 2004 Nobel Prize-winning scientist Aaron Chekhanov as its scientific advisor. Professor Aaron Chekhanowo was formerly a member of the Academic Committee of the “Key Laboratory of Childhood Development and Cognitive Disorders-Related Diseases Change,” and will use the research team of the Joint Research Center in the future in the joint transformation of childhood development and Alzheimer's disease. Conduct scientific research.
sign a contract
On October 21, 2011, the “International Development and Disease Summit Forum”, a sub-activity of the “Internationally Recognized R&D Agency Chongqing Action” was opened.
The Children's Hospital of Chongqing Medical University and the University of British Columbia of Canada signed an agreement at the forum to jointly create the "Children's Development and Alzheimer's Joint Translational Medical Research Center" in the Children's Hospital of Affiliated Hospital.
Li Tingyu, director of the Children's Hospital attached to the doctor's office, said that the global incidence of dementia in children is one in 1,000, which is a genetic disease with a high incidence. The University of British Columbia School of Medicine is the largest medical research center in Canada. Its brain research center is one of the key national research centers in Canada.